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Cervical Intramedullary Ganglioma
Harminder Singh MD, Ashwini Sharan MD, John K. Ratliff MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania

A 48 year male presented to the ER with severe headaches which were episodic in nature and which
had been present for several weeks. Patient had a history of traumatic head injury (TBI) several years
prior. Otherwise, he was in good health with no significant past medical or surgical history.
On physical exam, patient was oriented x 3 with an intact cranial nerve exam. He had significant
upper and lower extremity spasticity with mild hand intrinsic weakness. His motor exam was otherwise unremarkable. His gait was very spastic. He had sustained lower extremity clonus, upgoing
toes, and increased tone in the upper and lower extremities. His sensation was intact to light touch,
pinprick, proprioception and temperature.
What imaging studies would you order?
A CT scan of the brain was initially obtained secondary to the severity of the patients’ headaches and
past history of TBI.
The head CT revealed an old lacunar infarct in the left basal ganglia. There was no intracerebral hemorrhage or extra axial collection. However, in the spinal cord at the level of C1, an 8 mm hypodensity
was noted.
This prompted an MRI of the cervicomedullary junction. An ovoid, 1.1 x 1.0 x 1.7 cm intramedullary
lesion was seen expanding the cervical cord at the C1-2 level. It was hyperintense on T2-weighted
images and hypointense on T1 weighted images, and demonstrated some mild curvilinear enhancement within the lesion.

Figure 1
Pre-op axial non-contrast CT head showing
hypodensity within the spinal cord

What is your differential diagnosis? Would you perform any further imaging?
These radiographic findings were consistent with a low grade tumor such as an astrocytoma. An
ependymoma or cord metastasis were considered less likely.
No evidence for primary malignancy was found on imaging of the chest, abdomen and pelvis.
Imaging of the entire neural-axis did not reveal any other lesions.
A CSF flow study on MRI was also performed to look at CSF flow dynamics, and evaluate for possible CSF outflow obstruction secondary to this lesion, which might have explained the patient’s
headaches. Unobstructed CSF flow was identified anterior and posterior to the cervicomedullary
junction at the foramen magnum and at the level of the intramedullary lesion at C1-C2.
How would you treat this lesion?
A. Observation and close neurological follow up
B. Perform a lumbar puncture for CSF cytology
C. Radiation and/or chemotherapy

Figure 2

D. Excisional biopsy

Pre-op sagittal T1-weighted MRI

E. Excisional biopsy followed by radiation and/or chemotherapy
This is a young, otherwise healthy male who is starting to develop neurological symptoms from
a lesion with unknown pathology. Considering the rapid progression of his symptoms over a few
weeks, we felt that it was necessary to expediently secure him a diagnosis via direct exploration of the
lesion. Once the diagnosis was established, treatment tailored to his particular ailment could begin.
While operative exploration of this lesion entails risk of significant morbidity, we felt the severity of
his clinical findings and the progression of his deficit merited operative exploration.
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The diagnostic yield from CSF cytology is
low (~26%)(3), although repeated sampling
does increase the yield significantly. CSF flow
cytometry also increases the diagnostic yield
over CSF cytomorphology alone. (1) Newer
techniques like fluorescence in situ hybridization (FISH) enhance the diagnostic yield for
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the detection of malignancy on the first lumbar
puncture in patients clinically suspected of
having leptomeningeal metastases (LMM). (10)
Radiographic imaging did not demonstrate any
leptomeningeal spread in our patient. In the
absence of leptomeningeal spread, the chances
of obtaining a diagnosis from CSF cytology are
further diminished.

Figure 3

Figure 4

Pre-op sagittal T2-weighted MRI

Pre-op sagittal post-gadolinium MRI

Figure 5

Figure 6

Intraoperative ultrasound image, pre
resection

Intraoperative ultrasound image, post
resection

We decided to proceed with exploration and
biopsy of the tumor. We planned to debulk the
tumor and to possibly resect the entirety of the
tumor predicated upon the lesion’s histopathological findings at the time of frozen section and
intraoperative behavior. Debulking the tumor
would also alleviate the mass effect on the spinal
cord, decrease tumor burden, and afford the
patient a better chance at tumor control through
adjuvant chemotherapy and radiation.
How would you counsel the patient regarding
the surgical risks?
The risks and benefits of surgery were explained
at length. It was emphasized to the patient that
there was a substantial risk of neurologic worsening and a significant risk of paralysis secondary to the size of the tumor and its extremely
sensitive location. The patient had previously
suffered a significant head injury; hence, these
discussions were also carried out with patient’s
mother who acted as his guardian. While the
patient was felt to be thoroughly consentable,
the patient’s family was again counseled as to
the severity of his diagnosis and the significant
dangers of surgery.
What surgical approach would you
use? What intra-operative tools would
help you in localization of this lesion?
We decided to approach this lesion through a
posterior cervical approach. The patient was
positioned prone using the Mayfield three-pin
headholder. The patient’s neck was placed
in gentle flexion to facilitate exposure of the
occipitocervical junction. The posterior arch of
C1, along with 50% of the top of the lamina of
C2 was removed. At the base of the occiput, we
performed a limited suboccipital craniectomy
using the Midas-Rex drill.
The dura was opened next. Using intraoperative ultrasound localization, we identified the
patient’s large intramedullary tumor. We
attempted to map the spinal cords’ midline
using SSEPs; however, due to poor recordings
and extensive lateral spread, we were unable to
adequately map the posterior elements.

Figure 7

Figure 8

Post-operative sagittal CT

Post-operative sagittal MRI
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We chose an entry point along the posterior
elements. The spinal cord was entered via
bipolar and creating a sharp incision in the
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hemisphere gangliogliomas. Histological grade
was not predictive of outcome, although in each
location there was a trend for higher-grade
tumors to have a shorter time to recurrence.(6)
It is concluded that radical surgery leads to longterm survival of patients with gangliogliomas,
regardless of location, and adjuvant therapy
can probably be reserved for special cases (e.g.
tumors with a high KI 67 index). (4, 5, 7-9)
References
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Figure 10

Atypical ganglion cells including binucleated ganglion cell

Chromogranin staining of atypical ganglion
cells in background of neoplastic glial cells

pia mater. The cord was opened further using
microscissors. Using blunt dissection, we gently
reflected the pia-arachnoid. Using pial sutures,
we gently retracted the spinal cord bilaterally.
The patient’s intramedullary tumor was evident.
Using blunt dissection, we gently developed
a plane around the patient’s intramedullary
tumor. A biopsy was obtained and sent for
frozen section. Frozen section returned a lowgrade astrocytoma.
We continued our resection, removing as much
of the tumor as we felt safe. We periodically
checked motor evoked potentials during our
decompression. After we had completed our
decompression, we used the ultrasound to
confirm that no further gross elements of
tumor were evident. There was a gliotic shell,
which was evident around the spinal cord;
however, based on ultrasound localization, the
main portion of the patient’s tumor had been
successfully extirpated.
There was some mild loss of hand intrinsic
motor evoked potentials during the procedure;
however, this was less than 50% loss and was
not felt to be severe. After hemostasis had been
achieved, the wound was thoroughly irrigated.
The dura was closed using #6-0 Gore-Tex
sutures.
Postoperatively, the patient recovered well. His
motor and sensory exam remained stable.
Permanent section was consistent with that of
ganglioglioma.
Ganglioglioma was first described by Courville in
1930 as a central nervous system neoplasm containing both astrocytic and neuronal components.
Gangliogliomas are firm grayish tumors that
may have cystic components. On light microscopy, atypical dysplastic neurons, astrocytes, and
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fibrovascular stroma are observed. Infrequently,
anaplastic degeneration occurs and involves
the astrocytic component. Neoplastic ganglion
cells are large and mature and reveal intense
immunoreactivity with synaptophysin, show
expression of the stem cell epitope CD34, and
are often binucleated.
Most gangliogliomas are observed in the brain.
Temporal lobes and cerebellar hemispheres are
the most common locations. Rarely, they may
also develop in the spinal cord. Only 1% of
intramedullary spinal neoplasms are histologically gangliogliomas.
Now that diagnosis has been established,
would you recommend any further treatment
for this patient?
Radical surgery for intraspinal tumors can
achieve long tumor-free survival without
requiring adjuvant therapy.(4) In cases of lowgrade tumor, radical excision is associated with
minimal morbidity and an excellent long-term
prognosis when carried out before significant
disability occurs.(2) Gangliogliomas are generally classified as WHO grade 1 lesions; however,
malignant transformation can occur.
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In one study, the 5-year actuarial survival
rates for cerebral hemisphere, spinal cord, and
brain-stem gangliogliomas were 93%, 84%,
and 73%, respectively (p = 0.7). The event-free
survival rate at 5 years was 95% for cerebral
hemisphere gangliogliomas and 36% for spinal
cord gangliogliomas (p < 0.05); for brain-stem
gangliogliomas the event-free survival rate at 3
years was 53% (p < 0.05). Multivariate analysis
(Cox linear regression) revealed tumor location
to be the only variable predictive of outcome,
with spinal cord and brain-stem gangliogliomas
having a 3.5- and 5-fold increased relative risk of
recurrence, respectively, compared to cerebral
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